pCMV-Tag4A-MITF-M (wt) Citations (5)
Originally described in: Frequent mutations in the MITF pathway in melanoma.Cronin JC, Wunderlich J, Loftus SK, Prickett TD, Wei X, Ridd K, Vemula S, Burrell AS, Agrawal NS, Lin JC, Banister CE, Buckhaults P, Rosenberg SA, Bastian BC, Pavan WJ, Samuels Y Pigment Cell Melanoma Res. 2009 Aug . 22(4):435-44. PubMed Journal
Articles Citing pCMV-Tag4A-MITF-M (wt)
Articles |
---|
Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines. Noguchi K, Dalton AC, Howley BV, McCall BJ, Yoshida A, Diehl JA, Howe PH. PLoS One. 2017 May 17;12(5):e0177830. doi: 10.1371/journal.pone.0177830. eCollection 2017. PubMed |
Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1). Noguchi K, Dincman TA, Dalton AC, Howley BV, McCall BJ, Mohanty BK, Howe PH. J Biol Chem. 2018 Jul 20;293(29):11401-11414. doi: 10.1074/jbc.RA118.003616. Epub 2018 Jun 5. PubMed |
Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype. Polubothu S, Zecchin D, Al-Olabi L, Lionarons DA, Harland M, Horswell S, Thomas AC, Hunt L, Wlodarchak N, Aguilera P, Brand S, Bryant D, Carrera C, Chen H, Elgar G, Harwood CA, Howell M, Larue L, Loughlin S, MacDonald J, Malvehy J, Barberan SM, da Silva VM, Molina M, Morrogh D, Moulding D, Nsengimana J, Pittman A, Puig-Butille JA, Parmar K, Sebire NJ, Scherer S, Stadnik P, Stanier P, Tell G, Waelchli R, Zarrei M, Puig S, Bataille V, Xing Y, Healy E, Moore GE, Di WL, Newton-Bishop J, Downward J, Kinsler VA. Genet Med. 2021 Sep;23(9):1636-1647. doi: 10.1038/s41436-021-01204-y. Epub 2021 Jun 18. PubMed |
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis. Shabna A, Antony J, Vijayakurup V, Saikia M, Liju VB, Retnakumari AP, Amrutha NA, Alex VV, Swetha M, Aiswarya SU, Jannet S, Unni US, Sundaram S, Sherin DR, Anto NP, Bava SV, Chittalakkottu S, Ran S, Anto RJ. Cell Mol Life Sci. 2022 Aug 10;79(9):478. doi: 10.1007/s00018-022-04476-y. PubMed |
The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300. Brown AD, Lynch K, Langelaan DN. Sci Rep. 2023 Sep 26;13(1):16094. doi: 10.1038/s41598-023-43207-6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.